PROCEPT BioRobotics Corporation (PRCT) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT
Company Participants
Larry Wood – President, CEO & Director
Kevin Waters – Executive VP & CFO
Conference Call Participants
Stephanie Piazzola – BofA Securities, Research Division
Presentation
Stephanie Piazzola
BofA Securities, Research Division
Stephanie Piazzola, I cover medical devices at BofA. And next up, we have PROCEPT BioRobotics. We have Larry Wood, CEO; and Kevin Waters, CFO.
So thanks both for being here today.
Question-and-Answer Session
Stephanie Piazzola
BofA Securities, Research Division
Maybe we can start with Q1, you just reported revenue which beat by 3%. Systems were a little better and procedures were a little light versus the Street. So maybe you can just start high level with an overview and drivers of Q1 results.
Larry Wood
President, CEO & Director
Sure. Thanks for being here. Yes. I think coming out of Q4, there were a lot of questions that a lot of people had. We obviously had the big inventory reset. And I think there were a lot of concerns about systems being a little soft and pricing being a little soft.
And so, I think there were a lot of things that people had a lot of questions on. And what we really try to do is put a high-quality quarter on the board in Q1. I think we guided to the inventory issue being behind us, and we thought we’d be 1:1 on procedures for the full year. We were at 95% in Q1, which I think bodes really well for us being a 1:1 full year.
System placements, we’re very pleased. We did 47 greenfield placements, and we did at our highest price point that we’ve ever done, which I think represents the strength in capital, which I think people were concerning was
